| answer text |
<p>The NHS Long Term Plan and the second Life Sciences Sector Deal set out the Government
and National Health Service commitment to ensuring that patients are able to receive
the best treatments as fast as possible.</p><p> </p><p>From 2020, a new NHS England
health tech funding requirement will identify the best value innovations as ‘ready
to spread’ and help the NHS to adopt them quickly. This will apply to health tech
products which have been assessed as cost saving by the National Institute for Health
and Care Excellence (NICE). In addition, NICE will significantly increase the number
of evaluations it does for health tech products, so that the NHS has the evidence
it needs to decide the best products to adopt and spread.</p><p> </p><p>Improving
the adoption and spread of high quality innovations is also a priority for the Accelerated
Access Collaborative under the leadership of Lord Darzi. In October, they identified
12 products that should be supported for rapid spread across the NHS, and further
products will be identified this year. The Academic Health Science Networks are also
a key partner in supporting the adoption and spread of health tech across the system,
and the NHS Long Term Plan commits to their continued role in improving access to
innovation.</p>
|
|
